This independent HPLC lab test confirms Tirzepatide 10mg from Injectify at 99.715% purity. The analysis was conducted by Janoshik Labs on January 8, 2026.
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its role in metabolic regulation, weight management, and glycemic control. A purity level of 99.715% indicates high-grade synthesis with minimal contamination.
The full certificate of analysis is available for verification at www.janoshik.com/verify/ using the unique key THMM25ZN969D.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.